Latest Results From our Autumn Surveys

Interesting findings from two surveys we conducted in autumn about pivotal topics on health issues

Each year we conduct studies in conjunction with healthcare professionals and the general public worldwide. 

Our goal is to demonstrate how our research studies positively impact the healthcare industry and how vital your participation in market research is. 

This autumn we focused on two topics that cover women and men health, an attempt to give voice to the general public on two crucial elements in the healthcare landscape: breast cancer screenings and their importance in early detection and the Movember movement, which aims to raise awareness on prostate cancer, testicular cancer, mental health issues, and suicide prevention.

You can find the results of the two studies below.

By registering with M3 Global Research you will receive invites to paid market research surveys directly to your inbox. *

* Registration is free and only takes a few clicks. By registering to our panel, you will also be invited by email to our paid studies about a wide range of healthcare related topics

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.